Literature DB >> 17848299

Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer.

Michael S O'Reilly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17848299      PMCID： PMC2092454          DOI： 10.1016/j.ijrobp.2007.04.093

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  12 in total

1.  Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts.

Authors:  E L Lund; L Bastholm; P E Kristjansen
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

2.  Tumor angiogenesis and tissue factor.

Authors:  J Folkman
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

3.  A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.

Authors:  Zhongxing Liao; Ritsuko Komaki; Luka Milas; Chen Yuan; Merrill Kies; Joe Y Chang; Melenda Jeter; Thomas Guerrero; George Blumenschien; Cheryl M Smith; Frank Fossella; Barry Brown; James D Cox
Journal:  Clin Cancer Res       Date:  2005-05-01       Impact factor: 12.531

4.  Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy.

Authors:  Peter E Huber; Marc Bischof; Jürgen Jenne; Sabine Heiland; Peter Peschke; Rainer Saffrich; Hermann-Josef Gröne; Jürgen Debus; Kenneth E Lipson; Amir Abdollahi
Journal:  Cancer Res       Date:  2005-05-01       Impact factor: 12.701

5.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Authors:  Frank Winkler; Sergey V Kozin; Ricky T Tong; Sung-Suk Chae; Michael F Booth; Igor Garkavtsev; Lei Xu; Daniel J Hicklin; Dai Fukumura; Emmanuelle di Tomaso; Lance L Munn; Rakesh K Jain
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

6.  Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.

Authors:  D H Gorski; M A Beckett; N T Jaskowiak; D P Calvin; H J Mauceri; R M Salloum; S Seetharam; A Koons; D M Hari; D W Kufe; R R Weichselbaum
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

7.  In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.

Authors:  L Milas; K Mason; N Hunter; S Petersen; M Yamakawa; K Ang; J Mendelsohn; Z Fan
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

Review 8.  The biology of VEGF and its receptors.

Authors:  Napoleone Ferrara; Hans-Peter Gerber; Jennifer LeCouter
Journal:  Nat Med       Date:  2003-06       Impact factor: 53.440

9.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

10.  ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: schedule-dependent enhancement of antitumor activity.

Authors:  Kaye J Williams; Brian A Telfer; Sandra Brave; Jane Kendrew; Lynsey Whittaker; Ian J Stratford; Stephen R Wedge
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531
View more
  6 in total

1.  Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study.

Authors:  Leslie M Randall; Bradley J Monk; James Moon; Ricardo Parker; Muthana Al-Ghazi; Sharon Wilczynski; John P Fruehauf; Maurie Markman; Robert A Burger
Journal:  Gynecol Oncol       Date:  2010-09-16       Impact factor: 5.482

2.  Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.

Authors:  Ying Ren; Dominik Fleischmann; Kira Foygel; Lior Molvin; Amelie M Lutz; Albert C Koong; R Brooke Jeffrey; Lu Tian; Jürgen K Willmann
Journal:  Invest Radiol       Date:  2012-01       Impact factor: 6.016

3.  Dual targeting of tumor vasculature: combining Avastin and vascular disrupting agents (CA4P or OXi4503).

Authors:  Dietmar W Siemann; Wenyin Shi
Journal:  Anticancer Res       Date:  2008 Jul-Aug       Impact factor: 2.480

4.  Destruxins: fungal-derived cyclohexadepsipeptides with multifaceted anticancer and antiangiogenic activities.

Authors:  R Dornetshuber-Fleiss; P Heffeter; T Mohr; P Hazemi; K Kryeziu; C Seger; W Berger; R Lemmens-Gruber
Journal:  Biochem Pharmacol       Date:  2013-06-06       Impact factor: 5.858

5.  Surface modification of TPGS-b-(PCL-ran-PGA) nanoparticles with polyethyleneimine as a co-delivery system of TRAIL and endostatin for cervical cancer gene therapy.

Authors:  Yi Zheng; Hongbo Chen; Xiaowei Zeng; Zhigang Liu; Xiaojun Xiao; Yongqiang Zhu; Dayong Gu; Lin Mei
Journal:  Nanoscale Res Lett       Date:  2013-04-09       Impact factor: 4.703

6.  Co-delivery of docetaxel and endostatin by a biodegradable nanoparticle for the synergistic treatment of cervical cancer.

Authors:  Bo Qiu; Minghui Ji; Xiaosong Song; Yongqiang Zhu; Zhongyuan Wang; Xudong Zhang; Shu Wu; Hongbo Chen; Lin Mei; Yi Zheng
Journal:  Nanoscale Res Lett       Date:  2012-12-06       Impact factor: 4.703
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.